Science Explorer Interactive view Map
Company · Princeton · United States

Genmab (United States)

genmab.comROR OpenAlex
World rank, 2022–2025
#17,755
of 28,054 · #26,244 all time
Rank in United States
#2,544
of 4,192
Research works
178
▲ 239% vs 2013–17
Citations
2.2k
12.6 per fractional work
Top-10% rate
13.8%
record average 16.5%
Open access
51%
world 28%

What does Genmab (United States) specialise in?

Where its research is concentrated relative to its size: Oncology takes 17.8× the share of its output that it takes of world research.

  1. OncologySubfield · 20.2 works18×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.16× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.02× its world share, 16 worksBiochemistry, Geneti…Immunology and Microbiology: 6.89× its world share, 7 worksImmunology and Micro…Neuroscience: 0.04× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.84× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.08× its world share, 0 worksChemistryComputer Science: 0.71× its world share, 6 worksComputer ScienceEnergy: 0.18× its world share, 0 worksEnergyEngineering: 0.11× its world share, 2 worksEngineeringEnvironmental Science: 0.30× its world share, 2 worksEnvironmental ScienceMaterials Science: 0.01× its world share, 0 worksMaterials ScienceMathematics: 1.06× its world share, 1 worksMathematicsPhysics and Astronomy: 0.30× its world share, 1 worksPhysics and AstronomyDentistry: 0.34× its world share, 0 worksDentistryHealth Professions: 0.07× its world share, 0 worksHealth ProfessionsMedicine: 3.04× its world share, 59 worksMedicineNursing: 0.17× its world share, 0 worksNursingVeterinary: 0.72× its world share, 0 worksVeterinaryArts and Humanities: 0.57× its world share, 2 worksArts and HumanitiesBusiness, Management and Accounting: 0.01× its world share, 0 worksBusiness, Management…Decision Sciences: 1.57× its world share, 2 worksDecision SciencesEconomics, Econometrics and Finance: 0.49× its world share, 1 worksEconomics, Econometr…Psychology: 0.12× its world share, 0 worksPsychologySocial Sciences: 0.10× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.9×. Every wedge is a field page.

Who are the top researchers at Genmab (United States)?

Ranked on the composite score, Brandon W. Higgs, Han Si and Maria Jure‐Kunkel lead among researchers whose main affiliation is Genmab (United States).

  1. 1 Brandon W. Higgs United States · #291,302 worldwide 101 citations · 40 works
  2. 2 Han Si United States · #569,764 worldwide 37 citations · 21 works
  3. 3 Maria Jure‐Kunkel United States · #928,439 worldwide 16 citations · 30 works
  4. 4 Alex Mutebi United States · #973,494 worldwide 18 citations · 15 works
  5. 5 Sriram Sridhar United States · #1,009,695 worldwide 7 citations · 15 works
  6. 6 Mark Fereshteh United States · #1,465,344 worldwide 15 citations · 16 works
  7. 7 Jeremy D. Gale United States · #1,531,219 worldwide 4 citations · 17 works
All ranked researchers at Genmab (United States)

Which keywords describe research at Genmab (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Lymphoma, Rituximab, Immunotherapy, Cancer Immunotherapy, PET Imaging, Tumor Regression, Monoclonal Antibodies and Classification.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Lymphoma17▲ 106×2 topics
  2. Rituximab12▲ 80×2 topics
  3. Immunotherapy11▲ 15×10 topics
  4. Cancer Immunotherapy10▲ 64×3 topics
  5. PET Imaging10▲ 57×3 topics
  6. Tumor Regression10▲ 87×2 topics
  7. Monoclonal Antibodies9▲ 102×3 topics
  8. Classification9▲ 20×1 topic
  9. Molecular Profiling9▲ 92×1 topic
  10. CAR T Cells8▲ 109×1 topic
  11. Chimeric Antigen Receptor8▲ 109×1 topic
  12. Machine Learning8▲ 2.3×12 topics
  13. Tumor Microenvironment7▲ 16×7 topics
  14. Glycosylation7▲ 61×3 topics
  15. Therapeutic Antibodies7▲ 96×2 topics
  16. Chemotherapy7▲ 9.3×16 topics
  17. Antibody Engineering6▲ 115×1 topic
  18. Fc Receptors6▲ 115×1 topic
  19. Immune Checkpoint Blockade6▲ 54×1 topic
  20. PD-1 and PD-L16▲ 54×1 topic
  21. Targeted Therapy5▲ 23×5 topics
  22. Precision Medicine5▲ 11×5 topics
  23. Prognostic Factors5▲ 11×7 topics
  24. Medical Imaging4▲ 8.2×3 topics
  25. Predictive Modeling4▲ 13×2 topics
  26. Clinical Trials4▲ 5.3×7 topics
  27. Gene Expression4▲ 5.8×8 topics
  28. Texture Analysis3▲ 15×2 topics
  29. Therapeutic Targets3▲ 22×2 topics
  30. Quantitative Analysis3▲ 16×2 topics
  31. Feature Extraction3▲ 7.0×1 topic
  32. Radiomics3▲ 27×1 topic
  33. Biopharmaceuticals3▲ 57×3 topics
  34. Chronic Lymphocytic Leukemia3▲ 67×1 topic
  35. Genomic Aberrations3▲ 67×1 topic
  36. Immunogenicity3▲ 68×2 topics
  37. Immunity3▲ 6.8×5 topics
  38. Cancer Genomics3▲ 37×1 topic
  39. Genomic Instability3▲ 24×2 topics
  40. Mutational Signatures3▲ 37×1 topic

Which research topics does Genmab (United States) publish most on?

By volume in 2022–2025: Lymphoma Diagnosis and Treatment, CAR-T cell therapy research, Monoclonal and Polyclonal Antibodies Research and Cancer Immunotherapy and Biomarkers.

Lymphoma Diagnosis and T…9Lymphoma Diagnosis and Treatment: 9 fractional worksCAR-T cell therapy research: 8 fractional worksMonoclonal and Polyclonal Antibodies Research: 6 fractional worksCancer Immunotherapy and Biomarkers: 6 fractional worksRadiomics and Machine Learning in Medical Imaging: 3 fractional worksChronic Lymphocytic Leuk…3Chronic Lymphocytic Leukemia Research: 3 fractional worksCancer Genomics and Diagnostics: 3 fractional worksBiosimilars and Bioanalytical Methods: 2 fractional worksImmunotherapy and Immune Responses: 2 fractional worksHER2/EGFR in Cancer Research: 2 fractional works
Pathology and Forensic MedicineOncologyRadiology, Nuclear Medicine and ImagingGenetics2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 9 works
  2. 2 CAR-T cell therapy research Oncology 8 works
  3. 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 6 works
  4. 4 Cancer Immunotherapy and Biomarkers Oncology 6 works
  5. 5 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 3 works
  6. 6 Chronic Lymphocytic Leukemia Research Genetics 3 works
  7. 7 Cancer Genomics and Diagnostics Cancer Research 3 works
  8. 8 Biosimilars and Bioanalytical Methods Immunology 2 works
  9. 9 Immunotherapy and Immune Responses Immunology 2 works
  10. 10 HER2/EGFR in Cancer Research Oncology 2 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available51.2%not open48.8%

World: 28% of research is openly available.

with international co-authors53.3%domestic only46.7%

World: 19% is written across borders.

How has Genmab (United States)'s research output changed?

Output in 2018–2022 was 239% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Princeton

All research institutions in Princeton

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.